View drug registration information details.
Items | Registration information |
ID | 2849 |
No | 2849 |
Brand Name | KEFUCLAV 250 |
Ingredients | CEFUROXIME AXETIL USP 312.5 MG EQ.TO CEFUROXIME 250 MG, DILUTED POTASSIUM CLAVULANATE( WITH AVICEL) BP 148.81 MG EQ.TO CLAVULANIC ACID 62.5 MG |
Dosage Form | FILM-COATED TABLETS |
Primary Packaging | ALU-ALU STRIP |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 2 X 7'S |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | PHARYNGITIS/TONSILLITIS, ACUTE BACTERIAL OTITIS MEDIA, ACUTE BACTERIAL MAXILLARY SINUSITIS, ACUTE BACTERIAL EXACERBATIONS OF CHRONIC BRONCHITIS AND SECONDARY BACTERIAL INFECTIONS OF ACUTE BRONCHITIS, UNCOMPLICATED SKIN AND SKIN-STRUCTURE INFECTIONS, UNCOMPLICATED URINARY TRACT INFECTION, UNCOMPLICATED GONORRHEA. |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | LIGHT YELLOW TO YELLOW CAPLET SHAPE, DEEP BICONVEX FILM COATED TABLET, ONE SCORE ON ONE SIDE |
Note | |
License Owner | VIMPEX (LAO) CO.,LTD |
Manufacturer | ESKAYEF PHARMACEUTICALS LIMITED |
Country | BANGLADESH |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 07 I 4523/18 |
FDD Registration Date | 07-JUL-2025 |
Expiry Date | 06-JUL-2030 |
Back to drug list
|